|
|
|
|
|
|
|
|
Join this Clinical Leader Live on 9-22-26 to explore smarter ways to evaluate site capabilities, patient availability, recruitment potential, protocol burden, and virtual versus in-person trial activities. Discover how sponsors can move beyond feasibility paperwork to make better decisions about whether, where, and how a clinical trial can succeed. Register today to join the discussion.
|
|
|
|
|
|
|
|
Sustainable Engagement: Your Enrollment And Representation Depend On It
|
|
Guest Column | A conversation between Karen Correa, Ph.D., and Clinical Leader Executive Editor Abby Proch
|
Early and ongoing patient engagement is a crucial component to staving off recruitment trouble and securing proper patient representation. Boehringer Ingelheim's Karen Correa, Ph.D., explains how.
|
|
|
|
|
|
|
|
Enhancing The Accessibility And Affordability Of Healthcare
|
|
Article | By Rob Abbott, ISPOR—The Professional Society for Health Economics and Outcomes Research
|
The March/April 2025 issue of Value & Outcomes Spotlight explores the urgent global health crisis of accessibility and affordability, highlighting the nearly 2 billion individuals lacking essential medicines.
|
|
|
|
|
|
|
|
|
|
|
Clinical Leader’s Site Solutions Expo on October 7, 2026, will showcase solutions that help clinical trial sites manage growing operational demands. Attendees will learn about site activation, recruitment, patient support, payments, communication, and other services designed to reduce site burden and improve trial performance. Solution providers will demonstrate how their offerings can help sponsors, CROs, and sites execute clinical studies more effectively.
|
|
|
|
|
|
|
|
5 Informed Consent Fixes For Sponsors And Investigators
|
|
Guest Column | By Tasha Mohseni, RD Research Services, LLC
|
Informed consent has never been solely about documentation, but some sponsors has treated it as a checkbox exercise. Here, consultant Tasha Mohseni shares tips and fixs for how best to approach informed consent.
|
|
|
|
|
|
|
|
|
|
|
|
Redefining Vaccine Trial Recruitment
|
|
White Paper | Avacare
|
Modern vaccine trials demand flexible, transparent recruitment workflows. Discover strategies to overcome enrollment delays and build representative, diverse study cohorts.
|
|
|
|
|
|
A Guide To Harnessing The Value Of APAC For Global Trial Success
|
|
White Paper | By James Cheong, JingPing Yeo, Ph.D., Zhenfei Yin, and Sean Hart, Precision for Medicine
|
As Phase III costs and complexity rise, APAC offers faster enrollment, lower costs, and market access advantages, but capturing that value requires early planning and in-region expertise.
|
|
|
|
|
|
|
|
|
|
|
|
The SIP Problem Is Bigger Than SIP
|
|
From The Editor | By Dan Schell, Chief Editor, Clinical Leader
|
Sites continue to struggle with duplicated administrative work across too many sponsor and CRO systems. Current SIP users cite real frustrations with the platform, but their experiences also suggest the original goal of a shared, standardized site-information system remains highly relevant.
|
|
|
|
|
|
|
|
|
|
Dedicated Community Oncology Sites
|
|
Video | Flourish Research
|
Rapid activation, strong referral partnerships, diverse patient access, and specialized immunotherapy infrastructure are reshaping oncology research.
|
|
|
|
|
|
Your Trial Is In Jeopardy. Time Is Critical.
|
|
Product | 20/20 Onsite
|
Expert ophthalmic teams rescue clinical trials with stabilized studies, nationwide coverage, and eye assessments, helping protect endpoints and regain timeline control quickly.
|
|
|
| Connect With Clinical Leader: |
|
|
|
|
